BackRecursion Pharmaceuticals Overview
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Target Price

Analysts' 12-month price predictions for RXRX.

Share Price

$5.49

Average Target Price

$6.009.3% upside

1 analysts in the last 4 months

High: $6 | Low: $6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-02-28Leerink Partners$69.3% upsideOpen
2024-09-04NeedhamGil Blum$11100.4% upsideOpen
2024-09-03KeyBancScott Schoenhaus$12118.6% upsideOpen
2024-09-03JefferiesDennis Ding$69.3% upsideOpen
2024-06-26KeyBancScott Schoenhaus$16191.4% upsideOpen